Philip Hempleman has become a fan of Supernus Pharmaceuticals Inc (NASDAQ:SUPN). According to a recent filing with the Securities and Exchange Commission......
(read more)December 13 - Hedge Funds, News - Comments
Goldman Capital Management Inc has reduced its exposure to Bacterin International Holdings Inc (NYSEMKT:BONE). In a recent filing with the Securities......
(read more)December 12 - Hedge Funds, News - Comments
Sam Isaly‘s Orbimed Advisors focuses on healthcare investments, and it has now disclosed a change to its holdings of Response Biomedical Corp. (......
(read more)November 12 - Hedge Funds, News - Comments
Is Biogen Idec Inc. (NASDAQ:BIIB) a buy? In the financial blogosphere, there are a lot of analytical tools for Biogen Idec Inc. (NASDAQ:BIIB) traders......
(read more)August 31 - News - Comments
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors. Our research has shown that this information......
(read more)August 27 - Hedge Funds - Comments
Vocera Communications Inc (NYSE:VCRA) was in 14 hedge funds’ portfolio at the end of the first quarter of 2013. VCRA has experienced an increase......
(read more)June 14 - News - Comments
Given Imaging Ltd. (NASDAQ:GIVN) was in 14 hedge funds’ portfolio at the end of March. GIVN has seen an increase in enthusiasm from smart money......
(read more)June 13 - News - Comments
Is Array Biopharma Inc (NASDAQ:ARRY) a worthy stock to buy now? Investors who are in the know are buying. The number of bullish hedge fund bets advanced......
(read more)June 10 - News - Comments
In the smart money’s world, Samuel Isaly’s Orbimed Advisors reported a purchase of some 2.1 million shares of Ambit Biosciences Corp (NASDAQ:AMBI)......
(read more)May 31 - Hedge Funds, News - Comments
Editor’s Note: Related Tickers: Baidu.com, Inc. (ADR) (NASDAQ:BIDU), Micron Technology, Inc. (NASDAQ:MU), Yelp Inc (NYSE:YELP), Google Inc (NASDAQ......
(read more)April 18 - News - Comments
According to a 13G filed with the SEC, SAC Capital Advisors, a hedge fund managed by billionaire Steve Cohen, owned 2.4 million shares of Infinity Pharmaceuticals......
(read more)April 17 - Hedge Funds - Comments
Antares Pharma Inc (NASDAQ:ATRS) investors should pay attention to an increase in activity from the world’s largest hedge funds recently. In the......
(read more)April 16 - News - Comments
XOMA Corp (NASDAQ:XOMA) investors should pay attention to a decrease in hedge fund interest lately. If you’d ask most investors, hedge funds are......
(read more)April 15 - News - Comments
Endocyte, Inc. (NASDAQ:ECYT) shareholders have witnessed a decrease in hedge fund sentiment in recent months. In the financial world, there are tons of......
(read more)April 15 - News - Comments
Fluidigm Corporation (NASDAQ:FLDM) was in 7 hedge funds’ portfolio at the end of the fourth quarter of 2012. FLDM investors should pay attention......
(read more)April 15 - News - Comments
Is Uroplasty, Inc. (NASDAQ:UPI) an excellent investment now? The smart money is taking an optimistic view. The number of bullish hedge fund bets went......
(read more)April 12 - News - Comments
Given Imaging Ltd. (NASDAQ:GIVN) was in 9 hedge funds’ portfolio at the end of December. GIVN shareholders have witnessed a decrease in support......
(read more)April 6 - News - Comments
Dendreon Corporation (NASDAQ:DNDN) investors should pay attention to a decrease in support from the world’s most elite money managers recently.......
(read more)April 5 - News - Comments
According to a 13G filed with the SEC, Adage Capital Management, a large hedge fund managed by Phil Gross and Robert Atchinson, owns just over 4 million......
(read more)April 4 - Hedge Funds - Comments
MAKO Surgical Corp. (NASDAQ:MAKO) was in 13 hedge funds’ portfolio at the end of December. MAKO investors should pay attention to a decrease in......
(read more)April 3 - News - Comments
XenoPort, Inc. (NASDAQ:XNPT) was in 13 hedge funds’ portfolio at the end of December. XNPT investors should be aware of a decrease in activity from......
(read more)April 3 - News - Comments
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 12 hedge funds’ portfolio at the end of December. NBIX shareholders have witnessed a decrease......
(read more)April 3 - News - Comments
Natus Medical Inc (NASDAQ:BABY) was in 15 hedge funds’ portfolio at the end of December. BABY investors should pay attention to an increase in hedge......
(read more)April 2 - News - Comments
Is Impax Laboratories Inc (NASDAQ:IPXL) a buy right now? Prominent investors are taking a bullish view. The number of bullish hedge fund positions advanced......
(read more)April 2 - News - Comments
Sequenom, Inc. (NASDAQ:SQNM) was in 15 hedge funds’ portfolio at the end of December. SQNM shareholders have witnessed an increase in hedge fund......
(read more)March 29 - News - Comments
Is OraSure Technologies, Inc. (NASDAQ:OSUR) a buy right now? Prominent investors are buying. The number of long hedge fund positions increased by 1 in......
(read more)March 28 - News - Comments
Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a buy right now? Hedge funds are getting more bullish. The number of long hedge fund positions improved......
(read more)March 27 - News - Comments
Is Warner Chilcott Plc (NASDAQ:WCRX) the right pick for your portfolio? The smart money is selling. The number of long hedge fund positions dropped by......
(read more)March 25 - News - Comments
Life Technologies Corp. (NASDAQ:LIFE) has seen an increase in support from the world’s most elite money managers recently. In today’s marketplace......
(read more)March 21 - News - Comments
A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and......
(read more)February 5 - Insider Trading - Comments
Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets. The fund......
(read more)January 8 - Hedge Funds - Comments
Billionaire Ken Fisher isn’t only the head of Fisher Asset Management, but also a long-running Forbes columnist whose picks published in that magazine......
(read more)November 27 - Hedge Funds - Comments
Bristol Myers Squibb Co. (NYSE:BMY) is down 5% so far this year, as the company saw bad news break in early August when it suspended a trial for its prospective......
(read more)October 15 - Stock Analysis - Comments
Between April and June of this year, Orbimed Advisors sold 18% of its shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), finishing the second quarter......
(read more)October 1 - Hedge Funds - Comments
Orbimed Advisors, managed by Samuel Isaly, is a hedge fund with a focus on the healthcare sector. At the end of June, according to Orbimed’s 13F filing......
(read more)September 8 - Hedge Funds - Comments
Peter Kolchinsky’s RA Capital Management reported 7.32% passive stake in Endocyte Inc. (ECYT). According to a regulatory filing, now RA Capital Management......
(read more)December 27 - Hedge Funds - Comments
Samuel Isaly reported his amended 13F portfolio on November 23rd. He made a lot of changes to his original third quarter 13F which was filed a few days......
(read more)November 29 - Hedge Funds - Comments
Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th. According to the filing,......
(read more)November 22 - Hedge Funds, Insider Trading - Comments
Regeneron Pharmaceuticals Inc.’s (REGN) shares rose 13.73% in trading on Monday after U.S. regulators approved its “drug Eylea to treat a......
(read more)November 21 - Hedge Funds, Market Movers - Comments
Shares of Inhibitex (INHX) more than doubled Friday morning. The increase came “after the company released promising new data on its hepatitis C......
(read more)November 4 - Hedge Funds - Comments
Humana Inc (HUM) swelled from $80.24 a share at open on Monday to hit anew 52-week high of $87.32 a share after it “announced earnings of $444.8......
(read more)October 31 - Hedge Funds - Comments
Daniel Gold’s QVT Financial sold 650 thousand shares in Anadys Pharmaceuticals Inc. (ANDS) on October 17th. According to the firm’s Form 4 and amend......
(read more)October 20 - Hedge Funds, Insider Trading - Comments
Edwards Lifesciences Corp (EW) “third-quarter earnings rose 7.5% on a tax benefit as the heart-valve maker’s investments in its expected Sapien......
(read more)October 20 - Hedge Funds - Comments
